Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal

Summary by Bloomberg
AbbVie Inc. is in talks to acquire mental health therapeutics company Gilgamesh Pharmaceuticals in a deal highlighting growing takeover interest in the sector, according to people familiar with the matter.

1 Articles

BloombergBloomberg
Lean Left

AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal

AbbVie Inc. is in talks to acquire mental health therapeutics company Gilgamesh Pharmaceuticals in a deal highlighting growing takeover interest in the sector, according to people familiar with the matter.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Bloomberg broke the news in United States on Wednesday, July 30, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

North Chicago icon

North Chicago

News
For You
SearchBlindspotLocal